Sandia Holdings’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
2017
Q4
$3.43M Hold
2017
Q3
$3.79M Hold
2017
Q2
$3.44M Buy
2017
Q1
$2.25M Hold
2016
Q4
$2.34M Buy